A total of 38 women in the previously defined low-risk group were reclassified—4 carried a P variant and 34 a VUS in the BARD1, CDH1, MAP3K1, RAD51C, RAD51D, or TP53 gene—none of whom were diagnosed with breast cancer at the time of this study. This evidence concerns the gene RAD51C and breast carcinoma.